未登录

R

Rumi Murayama

chiba university

H指数:6

被引数:128

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antibiotic-induced Microbiome Depletion Selectively Reduces Baseline Hypothalamic Oxytocin Signaling without Affecting MDMA-induced Oxytocin Response in Rats

抗生素诱导的微生物组耗竭选择性降低大鼠基础下丘脑催产素信号，而不影响MDMA诱导的催产素反应

Clinical Psychopharmacology and Neuroscience

IF2.7

2026-05-010

PRE

Dietary sulforaphane glucosinolate alleviates stress–induced depression and demyelination through gut–brain axis modulation

膳食萝卜硫苷通过调节肠-脑轴缓解应激诱导的抑郁和脱髓鞘。

The Journal of Nutritional Biochemistry

IF0

2026-02-220

OAAI

Intermittent MDMA Attenuates Ovariectomy-induced Bone Loss via a Gut Microbiota-Bone Axis

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE

IF2.7

2025-11-012

OAAI

D-lactate in immune regulation and neuroinflammation: beyond microbial fermentation

D-乳酸盐在免疫调节和神经炎症中的作用：超越微生物发酵

Brain, Behavior, and Immunity

IF0

2025-09-270

OAAI

The vagus nerve-dependent lung-brain axis mediates brain demyelination following acute lung injury

brain behavior and immunity

IF3.5

2025-03-010

OAAI

Subdiaphragmatic vagotomy reduces hypothalamic oxytocin expression and blood levels after oral MDMA administration in male rats

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2025-03-010

OAAI

Repeated intermittent administration of 3,4-methylenedioxymethamphet-amine mitigates demyelination in the brain from cuprizone-treated mice

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2025-03-010

OAAI

Microbiome depletion by broad-spectrum antibiotics does not influence demyelination and remyelination in cuprizone-treated mice

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2025-02-010

OAAI

Effects of 3,4-methylenedioxymethamphetamine on the gut microbiota and metabolites in the small intestine, cecum, and colon of male rats

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2025-01-010

OAAI

Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-β1 activation

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2025-01-010

OAAI

Splenic γδ T cells mediate antidepressant and prophylactic actions of arketamine in lipopolysaccharide-induced depression in mice

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2024-12-010

OAAI

Transforming growth factor-β mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2024-12-015

OAAI

Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2024-12-015

OAAI

A role of gut-brain axis on prophylactic actions of arketamine in male mice exposed to chronic restrain stress

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2024-05-013

PRE

Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2023-12-0112

PRE